Istituto di ricovero e cura a carattere scientifico (IRCCS)

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women (2021) Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, Wahlstrom C, Pooley KA, et al. Journal article Sequential defects in cardiac lineage commitment and maturation cause hypoplastic left heart syndrome (2021) Krane M, Dressen M, Santamaria G, My I, Schneider CM, Dorn T, Laue S, et al. Journal article Association of quality of life (QOL) with overall survival (OS) in patients (pts) with HR+/HER2-advanced breast cancer (ABC) treated with ribociclib (RIB) plus endocrine therapy (ET) in the MONALEESA-3 (ML-3) and ML-7 trials (2021) Fasching P, Harbeck N, Jerusalem G, Colleoni MA, Neven P, Franke F, De Laurentiis M, et al. Conference contribution The role of kras mutations in cortical malformation and epilepsy surgery: A novel report of nevus sebaceous syndrome and review of the literature (2021) Pepi C, De Palma L, Trivisano M, Pietrafusa N, Lepri FR, Diociaiuti A, Camassei FD, et al. Journal article, Review article Comparability of Raman Spectroscopic Configurations: A Large Scale Cross-Laboratory Study (2020) Guo S, Beleites C, Neugebauer U, Abalde-Cela S, Afseth NK, Alsamad F, Anand S, et al. Journal article Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans (2020) Galletti G, De Simone G, Mazza EMC, Puccio S, Mezzanotte C, Bi TM, Davydov AN, et al. Journal article IL-17C amplifies epithelial inflammation in human psoriasis and atopic eczema (2020) Lauffer F, Jargosch M, Baghin , Krause L, Kempf W, Absmaier-Kijak M, Morelli M, et al. Journal article Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (2020) Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, et al. Journal article, Review article Preserving Mobility in Older Adults with Physical Frailty and Sarcopenia: Opportunities, Challenges, and Recommendations for Physical Activity Interventions (2020) Billot M, Calvani R, Urtamo A, Sanchez-Sanchez JL, Ciccolari-Micaldi C, Chang M, Roller-Wirnsberger R, et al. Journal article, Review article Overall survival (OS) results of the phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR plus ), human epidermal growth factor 2-negative (HER2-) advanced breast cancer (ABC) treated with fulvestrant (FUL) (+) ribociclib (RIB) (2019) Slamon DJ, Neven P, Chia S, Fasching P, De Laurentiis M, Im SA, Petrakova K, et al. Conference contribution